Stopped clinical trials give evidence for the value of genetics

A new analysis of clinical trials that were stopped early generates insights on the role of genetics in drug development and provides a new resource for researchers aiming to improve success rates of clinical trials.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature genetics 2024-09, Vol.56 (9), p.1766-1767
1. Verfasser: King, Emily
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1767
container_issue 9
container_start_page 1766
container_title Nature genetics
container_volume 56
creator King, Emily
description A new analysis of clinical trials that were stopped early generates insights on the role of genetics in drug development and provides a new resource for researchers aiming to improve success rates of clinical trials.
doi_str_mv 10.1038/s41588-024-01834-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3086061916</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3086061916</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-91b8901f355094c8046aa2fafb2e7cd54611382e91d3fb4f7c8b84dd257ea4193</originalsourceid><addsrcrecordid>eNp9kMtKxTAQhoMo3l_AhQTcuKnOJGmbrkTEGwgu1HVI08mx0tMek_aAb2_0eAEXrjKQb_6Z-Rg7QDhBkPo0Ksy1zkCoDFBLlck1to25KjIsUa-nGgrMFMhii-3E-AKASoHeZFuygjIXUG2zs4dxWCyo4a5r-9bZjo-htV3ks3ZJnJZtQ70j7ofAx2fiS9tNxAfPZ9TT2Lq4xzZ8wmn_691lT1eXjxc32d399e3F-V3mRF6MWYW1rgC9zHOolNOgCmuFt74WVLom7YwotaAKG-lr5Uuna62aRuQlWYWV3GXHq9xFGF4niqOZt9FR19mehikaCbpI11ZYJPToD_oyTKFP2xmJCCAFlJgosaJcGGIM5M0itHMb3gyC-dBrVnpN0ms-9RqZmg6_oqd6Ts1Py7fPBMgVENNXP6PwO_uf2HfD2YN3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3110032071</pqid></control><display><type>article</type><title>Stopped clinical trials give evidence for the value of genetics</title><source>Nature</source><source>Alma/SFX Local Collection</source><creator>King, Emily</creator><creatorcontrib>King, Emily</creatorcontrib><description>A new analysis of clinical trials that were stopped early generates insights on the role of genetics in drug development and provides a new resource for researchers aiming to improve success rates of clinical trials.</description><identifier>ISSN: 1061-4036</identifier><identifier>ISSN: 1546-1718</identifier><identifier>EISSN: 1546-1718</identifier><identifier>DOI: 10.1038/s41588-024-01834-3</identifier><identifier>PMID: 39075209</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>631/114/2164 ; 631/154 ; 631/208 ; Agriculture ; Animal Genetics and Genomics ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Clinical trials ; Datasets ; Disease ; Drug development ; Gene Function ; Genetics ; Genomics ; Human Genetics ; Hypotheses ; Mutation ; Natural language processing ; News &amp; Views ; news-and-views ; Pharmaceutical industry ; Proteins ; Success</subject><ispartof>Nature genetics, 2024-09, Vol.56 (9), p.1766-1767</ispartof><rights>Springer Nature America, Inc. 2024</rights><rights>Copyright Nature Publishing Group Sep 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-91b8901f355094c8046aa2fafb2e7cd54611382e91d3fb4f7c8b84dd257ea4193</cites><orcidid>0000-0003-1877-8673</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39075209$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>King, Emily</creatorcontrib><title>Stopped clinical trials give evidence for the value of genetics</title><title>Nature genetics</title><addtitle>Nat Genet</addtitle><addtitle>Nat Genet</addtitle><description>A new analysis of clinical trials that were stopped early generates insights on the role of genetics in drug development and provides a new resource for researchers aiming to improve success rates of clinical trials.</description><subject>631/114/2164</subject><subject>631/154</subject><subject>631/208</subject><subject>Agriculture</subject><subject>Animal Genetics and Genomics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Clinical trials</subject><subject>Datasets</subject><subject>Disease</subject><subject>Drug development</subject><subject>Gene Function</subject><subject>Genetics</subject><subject>Genomics</subject><subject>Human Genetics</subject><subject>Hypotheses</subject><subject>Mutation</subject><subject>Natural language processing</subject><subject>News &amp; Views</subject><subject>news-and-views</subject><subject>Pharmaceutical industry</subject><subject>Proteins</subject><subject>Success</subject><issn>1061-4036</issn><issn>1546-1718</issn><issn>1546-1718</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKxTAQhoMo3l_AhQTcuKnOJGmbrkTEGwgu1HVI08mx0tMek_aAb2_0eAEXrjKQb_6Z-Rg7QDhBkPo0Ksy1zkCoDFBLlck1to25KjIsUa-nGgrMFMhii-3E-AKASoHeZFuygjIXUG2zs4dxWCyo4a5r-9bZjo-htV3ks3ZJnJZtQ70j7ofAx2fiS9tNxAfPZ9TT2Lq4xzZ8wmn_691lT1eXjxc32d399e3F-V3mRF6MWYW1rgC9zHOolNOgCmuFt74WVLom7YwotaAKG-lr5Uuna62aRuQlWYWV3GXHq9xFGF4niqOZt9FR19mehikaCbpI11ZYJPToD_oyTKFP2xmJCCAFlJgosaJcGGIM5M0itHMb3gyC-dBrVnpN0ms-9RqZmg6_oqd6Ts1Py7fPBMgVENNXP6PwO_uf2HfD2YN3</recordid><startdate>20240901</startdate><enddate>20240901</enddate><creator>King, Emily</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SS</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1877-8673</orcidid></search><sort><creationdate>20240901</creationdate><title>Stopped clinical trials give evidence for the value of genetics</title><author>King, Emily</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-91b8901f355094c8046aa2fafb2e7cd54611382e91d3fb4f7c8b84dd257ea4193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>631/114/2164</topic><topic>631/154</topic><topic>631/208</topic><topic>Agriculture</topic><topic>Animal Genetics and Genomics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Clinical trials</topic><topic>Datasets</topic><topic>Disease</topic><topic>Drug development</topic><topic>Gene Function</topic><topic>Genetics</topic><topic>Genomics</topic><topic>Human Genetics</topic><topic>Hypotheses</topic><topic>Mutation</topic><topic>Natural language processing</topic><topic>News &amp; Views</topic><topic>news-and-views</topic><topic>Pharmaceutical industry</topic><topic>Proteins</topic><topic>Success</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>King, Emily</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>King, Emily</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stopped clinical trials give evidence for the value of genetics</atitle><jtitle>Nature genetics</jtitle><stitle>Nat Genet</stitle><addtitle>Nat Genet</addtitle><date>2024-09-01</date><risdate>2024</risdate><volume>56</volume><issue>9</issue><spage>1766</spage><epage>1767</epage><pages>1766-1767</pages><issn>1061-4036</issn><issn>1546-1718</issn><eissn>1546-1718</eissn><abstract>A new analysis of clinical trials that were stopped early generates insights on the role of genetics in drug development and provides a new resource for researchers aiming to improve success rates of clinical trials.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>39075209</pmid><doi>10.1038/s41588-024-01834-3</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-1877-8673</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1061-4036
ispartof Nature genetics, 2024-09, Vol.56 (9), p.1766-1767
issn 1061-4036
1546-1718
1546-1718
language eng
recordid cdi_proquest_miscellaneous_3086061916
source Nature; Alma/SFX Local Collection
subjects 631/114/2164
631/154
631/208
Agriculture
Animal Genetics and Genomics
Biomedical and Life Sciences
Biomedicine
Cancer Research
Clinical trials
Datasets
Disease
Drug development
Gene Function
Genetics
Genomics
Human Genetics
Hypotheses
Mutation
Natural language processing
News & Views
news-and-views
Pharmaceutical industry
Proteins
Success
title Stopped clinical trials give evidence for the value of genetics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T08%3A55%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stopped%20clinical%20trials%20give%20evidence%20for%20the%20value%20of%20genetics&rft.jtitle=Nature%20genetics&rft.au=King,%20Emily&rft.date=2024-09-01&rft.volume=56&rft.issue=9&rft.spage=1766&rft.epage=1767&rft.pages=1766-1767&rft.issn=1061-4036&rft.eissn=1546-1718&rft_id=info:doi/10.1038/s41588-024-01834-3&rft_dat=%3Cproquest_cross%3E3086061916%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3110032071&rft_id=info:pmid/39075209&rfr_iscdi=true